YBX1 Confers immunosuppressive bone metastatic traits in non-small cell lung cancer
Kai Zhang, Bin Li, Qingshui Wang, Xiuli Zhang, Cheng Cheng, Mengyao Lv, Mengyang Huang, Zihui Liang, Zijie Xie, Yao Lin, Yang Zhao, Lilin Ge, Jing Chen · 2026
Read YBX1 Confers immunosuppressive bone metastatic traits in non-small cell lung cancer by Kai Zhang, Bin Li, Qingshui Wang, Xiuli Zhang, Cheng Cheng, Mengyao Lv, Mengyang Huang, Zihui Liang, Zijie Xie, Yao Lin, Yang Zhao, Lilin Ge, Jing Chen (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13407896.txt.
Description
Kai Zhang and co-authors identify, in 2026, a single protein that drives lung cancer's spread to bone and its resistance to immunotherapy. YBX1 is a gene-control factor. It switches on separate signalling routes for the two harms. One messenger pathway feeds bone metastasis. Another builds an immune-suppressed neighbourhood. That blunts treatment in non-small cell lung cancer.
A sugar tag sets the protein's own levels. The tag marks it for self-eating disposal inside the cell. Highly bone-spreading cancer cells carried less of that tag. YBX1 stayed abundant as a result. A drug candidate named icaritin restored the tagging and destroyed YBX1, which in the reported work both blocked bone spread and re-sensitised tumours to immune attack. One target for two problems is the attraction.
Catalog record
| CREATOR | Kai Zhang, Bin Li, Qingshui Wang, Xiuli Zhang, Cheng Cheng, Mengyao Lv, Mengyang Huang, Zihui Liang, Zijie Xie, Yao Lin, Yang Zhao, Lilin Ge, Jing Chen |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 84767 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |